From: A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (≥ 65 vs. < 65) | 1.09(0.76,1.54) | 0.65 | - | - |
Gender (Female vs. Male) | 0.88(0.61,1.27) | 0.487 | - | - |
Family history of cancer (Yes vs. No) | 0.92(0.63,1.36) | 0.683 | - | - |
TNM stage (II vs. I) | 1.7(1.12,2.6) | 0.014 | 1.78(1.05,3.02) | 0.032 |
TNM stage (III vs. I) | 2.84(1.89,4.26) | < 0.001 | 2.73(1.65,4.52) | < 0.001 |
TNM stage (IV vs. I) | - | - | - | - |
Histologic grade (G3–G4 vs. G1–G2) | 1.26(0.89,1.77) | 0.197 | - | - |
Ishak score (5–6 vs. 0–4) | 1.32(0.87,2.01) | 0.196 | - | - |
Child–Pugh grade (B–C vs. A) | 1.43(0.74,2.76) | 0.287 | - | - |
Vascular invasion (Micro vs. None) | 1.35(0.89,2.05) | 0.161 | 0.92(0.56,1.5) | 0.735 |
Vascular invasion (Macro vs. None) | 2.82(1.34,5.92) | 0.006 | 2.4(1.12,5.18) | 0.025 |
Alpha fetoprotein (Positive vs. Negative) | 1.08(0.74,1.59) | 0.691 | - | - |
Residual tumor (R1–R2 vs. R0) | - | - | - | - |
POLD1 (High vs. Low) | 1.36(1.08,1.71) | 0.01 | 1.29(0.99,1.68) | 0.057 |